Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1979-06-19
1982-05-25
Nucker, Christine M.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
2601125R, 2602395, 424179, 424238, A61K 4300, G01N 3356, G01N 3360, C07C10352
Patent
active
043316468
ABSTRACT:
The compound is constituted by a conjugate compound of an antigen having a free carboxylic function and a dipeptide. The dipeptide is constituted by a product of condensation between tyrosine and a peptide, the tyrosine group of the dipeptide being labeled with radioactive iodine.
The compound is highly soluble in water and permits of good recognition by the antibody in antigen-antibody reactions.
REFERENCES:
patent: 4197286 (1980-04-01), Rao
patent: 4202874 (1980-05-01), Akerkar et al.
patent: 4207308 (1980-06-01), Spenny
patent: 4209614 (1980-06-01), Bernstein et al.
Radioimmunoassay of Biologically Active Compounds, Parker, Prentice-Hall, Inc., N.J., 1976, pp. 93-94.
Ohki et al., Prostaglandins, vol. 6, No. 2, Apr. 1974, pp. 137-148.
Commissariat a l''Energie Atomique
Nucker Christine M.
LandOfFree
Iodine compound for use as a tracer in radioimmunology does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Iodine compound for use as a tracer in radioimmunology, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Iodine compound for use as a tracer in radioimmunology will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2076598